Indraprastha Medical Q2 Revenue Grows 8.4% to Rs 412.85 Crore

Revenue at Rs 412.85 crore and Net Profit at Rs 53.58 crore for the quarter ended September 30, 2026.

Reader Takeaway: Consistent year-on-year growth driven by operations, though rising professional and staff costs are pressuring sequential profit margins.

What just happened

Indraprastha Medical Corporation Ltd released its financial results for the second quarter of the fiscal year ending September 30, 2026. The company posted a revenue from operations of Rs 412.85 crore, up 8.4% from the Rs 381.03 crore reported in the same period last year. Net profit stood at Rs 53.58 crore, representing an 8.3% increase compared to the Rs 49.46 crore recorded in Q2 of the previous year.

Why this matters

The financial results highlight a stable growth path for the hospital operator. While year-on-year performance shows healthy expansion, the sequential data reveals rising operational headwinds. Revenue saw a modest increase from the previous quarter, but net profit dipped slightly from Rs 55.85 crore in June 2026, signaling that management is managing higher expenditure levels.

Cost and Expense Analysis

Total expenses for the quarter rose to Rs 349.33 crore, up from Rs 322.09 crore in Q2 last year. The primary cost drivers included professional charges to doctors, which rose to Rs 111.53 crore from Rs 99.50 crore, and employee benefit expenses, which climbed to Rs 78.53 crore from Rs 73.58 crore.

Balance Sheet Update

The company's asset base strengthened significantly, reaching Rs 1,118.44 crore as of September 30, 2026, compared to Rs 991.36 crore as of March 31, 2026. Other equity also saw an expansion to Rs 722.76 crore.

Governance

The Board of Directors approved these results on October 29, 2026. Statutory auditors S N Dhawan & Co LLP provided an unmodified limited review report, indicating no major accounting concerns during their review.